IBD across the age spectrum - Is it the same disease?

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 2, 2014, Pages 88-98

  Ruel, Joannie ^a   Ruane, Darren ^a   Mehandru, Saurabh ^a   Gower Rousseau, Corinne ^a   Colombel, Jean Frédéric ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGING; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; PHENOTYPE; PREVALENCE; YOUNG ADULT;

EID: 84893779346     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2013.240     Document Type: Review

References (182)

1. Virgin, H. W. &Todd, J. A. Metagenomics and personalized medicine. Cell 147, 44-56 (2011).
2. Gower-Rousseau, C. et al. Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD). Dig. Liv. Dis. 45, 89-94 (2013).
3. Charpentier, C. et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut http://dx.doi.org/10.1136/ gutjnl-2012-303864 (2013).
4. Cosnes, J., Gower-Rousseau, C., Seksik, P. &Cortot, A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140, 1785-1794 (2011).
5. Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel disease with time, based on systematic review. Gastroenterology 142, 46-54 (2012).
6. Kelsen, J. &Baldassano, R. N. Inflammatory bowel disease: the difference between children and adults. Inflamm. Bowel Dis. 14 (Suppl. 2), S9-S11 (2008).
7. Travis, S. Is IBD different in the elderly? Inflamm. Bowel Dis. 14 (Suppl. 2), S12-S13 (2008).
8. Bernstein, C. N. et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol. 101, 1559-1568 (2006).
9. Loftus, E. V. Jr et al. Crohns disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 114, 1161-1168 (1998).
10. Loftus, E. V. Jr et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 46, 336-343 (2000).
11. Van Limbergen, J. et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135, 1114-1122 (2008).
12. Kariyawasam, V. C. et al. Natural history of elderly onset inflammatory bowel disease-Sydney IBD cohort (1942-2012). Gastroenterology 144 (Suppl. 1), Mo1314 (2013).
13. Mamula, P. et al. Inflammatory bowel disease in children 5 years of age and younger. Am. J. Gastroenterol. 97, 2005-2010 (2002).
14. Gupta, N. et al. Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics 120, 1418-1425 (2007).
15. Shivananda, S. et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39, 690-697 (1996).
16. Auvin, S. et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J. Pediatr. Gastroenterol. Nutr. 41, 49-55 (2005).
17. Ostman, J. et al. Gender differences and temporal variation in the incidence of type one diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002. J. Intern. Med. 263, 386-394 (2008).
18. Guariso, G. et al. Inflammatory bowel disease developing in paediatric and adult age. J. Pediatr. Gastroenterol. Nutr. 51, 698-707 (2010).
19. Turunen, P. et al. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm. Bowel Dis. 12, 677-683 (2006).
20. Henderson, P. et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm. Bowel Dis. 18, 999-1005 (2012).
21. Hope, B. et al. Rapid rise in incidence of Irish paediatric inflammatory bowel disease. Arch. Dis. Child. 97, 590-594 (2012).
22. Jakobsen, C. et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: a prospective population-based cohort study 2007-2009. Inflamm. Bowel Dis. 17, 2541-2550 (2011).
23. Benchimol, E. I. et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm. Bowel Dis. 17, 423-439 (2011).
24. Chouraki, V. et al. The changing pattern of Crohns disease incidence in northern France: a continuing increase in the 10-To 19-year-old age bracket (1988-2007). Aliment. Pharmacol. Ther. 33, 1133-1142 (2011).
25. Economou, M. et al. Crohns disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants. World J. Gastroenterol. 13, 5116-5120 (2007).
26. Molini, F. et al. Opposite evolution in incidence of Crohns disease and ulcerative colitis in Northern France (1988-1999). Gut 53, 843-848 (2004).
27. Vernier-Massouille, G. et al. Natural history of pediatric Crohns disease: a population-based cohort study. Gastroenterology 135, 1106-1113 (2008).
28. Benchimol, E. I. et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 58, 1490-1497 (2009).
29. Malaty, H. M., Fan, X., Opekun, A. R., Thibodeaux, C. &Ferry, G. D. Rising incidence of inflammatory bowel disease among children: a 12-year study. J. Pediatr. Gastroenterol. Nutr. 50, 27-31 (2010).
30. Armitage, E., Drummond, H. E., Wilson, D. C. &Ghosh, S. Increasing incidence of both juvenile-onset Crohns disease and ulcerative colitis in Scotland. Eur. J. Gastroenterol. Hepatol. 13, 1439-1447 (2001).
31. Braegger, C. P. et al. Epidemiology of inflammatory bowel disease: is there a shift towards onset at a younger age? J. Pediatr. Gastroenterol. Nutr. 53, 141-144 (2011).
32. Burisch, J. et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut http://dx.doi.org/10.1136/gutjnl-2013-304636.
33. Bernstein, C. N., Blanchard, J. F., Rawsthorne, P. &Wajda, A. Epidemiology of Crohns disease and ulcerative colitis in a central Canadian province: a population-based study. Am. J. Epidemiol. 149, 916-924 (1999).
34. Piront, P., Louis, E., Latour, P., Plomteux, O. &Belaiche, J. Epidemiology of inflammatory bowel diseases in the elderly in the province of Lige. Gastroenterol. Clin. Biol. 26, 157-161 (2002).
35. Heresbach, D. et al. Crohns disease in the over-60 age group: a population based study. Eur. J. Gastroenterol. Hepatol. 16, 657-664 (2004).
36. Loftus, C. G. et al. Update on the incidence and prevalence of Crohns disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm. Bowel Dis. 13, 254-261 (2007).
37. Heyman, M. B. et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J. Pediatr. 146, 35-40 (2005).
38. Paul, T. et al. Distinct phenotype of early childhood inflammatory bowel disease. J. Clin. Gastroenterol. 40, 583-586 (2006).
39. Langholz, E., Munkholm, P., Krasilnikoff, P. A. &Binder, V. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand. J. Gastroenterol. 32, 139-147 (1997).
40. Freeman, H. J. Comparison of longstanding pediatric-onset and adult-onset Crohns disease. J. Pediatr. Gastroenterol. Nutr. 39, 183-186 (2004).
41. Mller, K. E. et al. Incidence, Paris classification and follow-up in a nationwide, incident cohort of pediatric patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 57, 576-582 (2013).
42. Kugathasan, S. et al. Wisconsin Pediatric Inflammatory Bowel Disease Alliance. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J. Pediatr. 143, 525-531 (2003).
43. Sauer, C. G. &Kugathasan, S. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Med. Clin. North Am. 94, 35-52 (2010).
44. Juneja, M. et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig. Dis. Sci. 57, 2408-2415 (2012).
45. Lakatos, P. L. et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J. Crohns Colitis 5, 5-13 (2011).
46. Harper, P. C., McAuliffe, T. &Beeken, W. L. Crohns disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch. Intern. Med. 146, 753-755 (1986).
47. Riegler, G. et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig. Dis. Sci. 45, 462-465 (2000).
48. Zimmerman, J., Gavish, D. &Rachmilewitz, D. Early and late onset ulcerative colitis: distinct clinical features. J. Clin. Gastroenterol. 7, 492-498 (1985).
49. Levine, A. et al. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm. Bowel Dis. 19, 370-377 (2013).
50. Griffiths, A. M., Nguyen, P., Smith, C., MacMillan, J. H. &Sherman, P. M. Growth and clinical course of children with Crohns disease. Gut 34, 939-943 (1993).
51. Hildebrand, H., Karlberg, J. &Kristiansson, B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 18, 165-173 (1994).
52. Markowitz, J., Grancher, K., Rosa, J., Aiges, H. &Daum, F. Growth failure in pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 16, 373-380 (1993).
53. Pigneur, B. et al. Natural history of Crohns disease: comparison between childhood-And adult-onset disease. Inflamm. Bowel Dis. 16, 953-961 (2010).
54. Lee, J. J. et al. Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score. Inflamm. Bowel Dis. 16, 1669-1677 (2010).
55. Wagtmans, M. J., Verspaget, H. W., Lamers, C. B. &van Hogezand, R. A. Crohns disease in the elderly: a comparison with younger adults. J. Clin. Gastroenterol. 27, 129-133 (1998).
56. Israeli, E., Ryan, J. D., Shafer, L. A. &Bernstein, C. N. Younger age at diagnosis is associated with panenteric, but not more aggressive, Crohns disease. Clin. Gastroenterol. Hepatol. http://dx.doi.org/10.1016/j.cgh.2013.06. 027.
57. Freeman, H. J. Long-Term prognosis of early-onset Crohns disease diagnosed in childhood or adolescence. Can. J. Gastroenterol. 18, 661-665 (2004).
58. Cosnes, J. et al. Long-Term evolution of disease behavior of Crohns disease. Inflamm. Bowel Dis. 8, 244-250 (2002).
59. Baldassano, R. N. et al. Pediatric Crohns disease: risk factors for postoperative recurrence. Am. J. Gastroenterol. 96, 2169-2176 (2001).
60. Besnard, M. et al. Postoperative outcome of Crohns disease in 30 children. Gut 43, 634-638 (1998).
61. El-Baba, M., Lin, C. H., Klein, M. &Tolia, V. Outcome after surgical intervention in children with chronic inflammatory bowel disease. Am. Surg. 62, 1014-1017 (1996).
62. Griffiths, A. M., Wesson, D. E., Shandling, B., Corey, M. &Sherman, P. M. Factors influencing postoperative recurrence of Crohns disease in childhood. Gut 32, 491-495 (1991).
63. Sedgwick, D. M., Barton, J. R., Hamer-Hodges, D. W., Nixon, S. J. &Ferguson, A. Population-based study of surgery in juvenile onset Crohns disease. Br. J. Surg. 78, 171-175 (1991).
64. Boualit, M. et al. Long-Term outcome after first intestinal resection in pediatric-onset Crohns disease: a population-based study. Inflamm. Bowel Dis. 19, 7-14 (2013).
65. Gower-Rousseau, C. et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am. J. Gastroenterol. 104, 2080-2088 (2009).
66. Hyams, J. S. et al. Clinical outcome of ulcerative colitis in children. J. Pediatr. 129, 81-88 (1996).
67. Malaty, H. M., Abraham, B. P., Mehta, S., Garnett, E. A. &Ferry, G. D. The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study. Clin. Exp. Gastroenterol. 6, 77-83 (2013).
68. Magro, F. et al. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm. Bowel Dis. 18, 573-583 (2012).
69. Polito, J. M. et al. Crohns disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111, 580-586 (1996).
70. Carbonnel, F., Macaigne, G., Beaugerie, L., Gendre, J. P. &Cosnes, J. Crohns disease severity in familial and sporadic cases. Gut 44, 91-95 (1999).
71. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
72. Brant, S. R. Promises, delivery, and challenges of inflammatory bowel disease risk gene discovery, Clin. Gastroenterol. Hepatol. 11, 22-26 (2013).
73. Cho, J. H. &Brant, S. R. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 140, 1704-1712 (2011).
74. Lesage, S. et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70, 845-857 (2002).
75. Cho, J. H. Advances in the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 6, 467-473 (2004).
76. Weiss, B. et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohns disease. J. Pediatr. 145, 208-212 (2004).
77. Kugathasan, S. et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet. 40, 1211-1215 (2008).
78. Imielinski, M. et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat. Genet. 41, 1335-1340 (2009).
79. de Ridder, L. et al. Genetic susceptibility has a more important role in pediatric-onset Crohns disease than in adult-onset Crohns disease. Inflamm. Bowel Dis. 13, 1083-1092 (2007).
80. Glocker, E. O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009).
81. Glocker, E. O. et al. Infant colitis-its in the genes. Lancet 376, 1272 (2010).
82. Worthey, E. A. et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 13, 255-262 (2011).
83. Blaydon, D. C. et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 365, 1502-1508 (2011).
84. Muise, A. M. et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 61, 1028-1035 (2012).
85. Matute, J. D. et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 114, 3309-3315 (2009).
86. Kotlarz, D. et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 143, 347-355 (2012).
87. Moran, C. J. et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm. Bowel Dis. 19, 115-123 (2013).
88. Odes, H. S. et al. Effects of current cigarette smoking on clinical course of Crohns disease and ulcerative colitis. Dig. Dis. Sci. 46, 1717-1721 (2001).
89. Bjarnason, I. et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93, 480-489 (1987).
90. Radford-Smith, G. L. et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohns disease. Gut 51, 808-813 (2002).
91. Soon, I. S. et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-Analysis. BMC Gastroenterol. 12, 51 (2012).
92. Baron, S. et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54, 357-363 (2005).
93. Molodecky, N. A. &Kaplan, G. G. Environnemental risk factors for inflammatory bowel disease. Gastroenterol. Hepatol. 6, 339-346 (2010).
94. Ananthakrishnan, A. N. Environmental risk factors for inflammatory bowel disease. Gastroenterol. Hepatol. 9, 367-374 (2013).
95. Cosnes, J., Beaugerie, L., Carbonnel, F. &Gendre, J. P. Smoking cessation and the course of Crohns disease: an intervention study. Gastroenterology 120, 1093-1099 (2001).
96. Boyko, E. J., Perera, D. R., Koepsell, T. D., Keane, E. M. &Inui, T. S. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand. J. Gastroenterol. 23, 1147-1152 (1988).
97. Lakatos, P. L. Environmental factors affecting inflammatory bowel disease: have we made progress? Dig. Dis. 27, 215-225 (2009).
98. Klement, E. et al. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am. J. Gastroenterol. 103, 1775-1782 (2008).
99. Koloski, N. A., Bret, L. &Radford-Smith, G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J. Gastroenterol. 14, 165-173 (2008).
100. López-Serrano, P. et al. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand. J. Gastroenterol. 45, 1464-1471 (2010).
101. Askling, J., Grahnquist, L., Ekbom, A. &Finkel, Y. Incidence of paediatric Crohns disease in Stockholm, Sweden. Lancet 354, 1179 (1999).
102. Yao, T., Matsui, T. &Hiwatashi, N. Crohns disease in Japan: diagnostic criteria and epidemiology. Dis. Colon Rectum. 43 (Suppl. 10), S85-S93 (2000).
103. Williams, M. E. et al. Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens. J. Infect. Dis. 170, 946-954 (1994).
104. Satoguina, J. et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect. 4, 1291-1300 (2002).
105. King, C. L. et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J. Immunol. 156, 4715-4721 (1996).
106. Castiglione, F. et al. Risk factors for inflammatory bowel diseases according to the hygiene hypothesis: a case-control, multi-centre, prospective study in Southern Italy. J. Crohns Colitis 6, 324-329 (2012).
107. Hildebrand, H., Malmborg, P., Askling, J., Ekbom, A. &Montgomery, S. M. Early-life exposures associated with antibiotic use and risk of subsequent Crohns disease. Scand. J. Gastroenterol. 43, 961-966 (2008).
108. Shaw, S. Y., Blanchard, J. F. &Bernstein, C. N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J. Gastroenterol. 105, 2687-2692 (2010).
109. Shaw, S. Y., Blanchard, J. F. &Bernstein, C. N. Association between the use of antibiotics and new diagnoses of Crohns disease and ulcerative colitis. Am. J. Gastroenterol. 106, 2133-2142 (2011).
110. Virta, L., Auvinen, A., Helenius, H., Huovinen, P. &Kolho, K. L. Association of repeated exposure to antibiotics with the development of pediatric Crohns disease-A nationwide, register-based Finnish case-control study. Am. J. Epidemiol. 175, 775-784 (2012).
111. Cornish, J. A. et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-Analysis. Am. J. Gastroenterol. 103, 2394-2400 (2008).
112. Khalili, H. et al. Hormone therapy increases risk of ulcerative colitis but not Crohns disease. Gastroenterology 143, 1199-1206 (2012).
113. Chan, S. S. et al. Aspirin in the aetiology of Crohns disease and ulcerative colitis: a European prospective cohort study. Aliment. Pharmacol. Ther. 34, 649-655 (2011).
114. Ananthakrishnan, A. N. et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann. Intern. Med. 156, 350-359 (2012).
115. Sellon, R. K. et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231 (1998).
116. Wild, G. E. The role of antibiotics in the management of Crohns disease. Inflamm. Bowel Dis. 10, 321-323 (2004).
117. Rutgeerts, P. et al. Effect of faecal stream diversion on recurrence of Crohns disease in the neoterminal ileum. Lancet 338, 771-774 (1991).
118. Rautava, S., Luoto, R., Salminen, S. &Isolauri, E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat. Rev. Gastroenterol. Hepatol. 9, 565-576 (2012).
119. Mackie, R. I., Sghir, A. &Gaskins, H. R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69, 1035S-1045S (1999).
120. Gurin-Danan, C. et al. Pattern of metabolism and composition of the fecal microflora in infants 10 to 18 months old from day care centers. J. Pediatr. Gastroenterol. Nutr. 25, 281-289 (1997).
121. Faith, J. J. et al. The long-Term stability of the human gut microbiota. Science 341, 1237439 (2013).
122. Mitsuoka, T. Intestinal flora and aging. Nutr. Rev. 50, 438-446 (1992).
123. Mitsuoka, T. &Hayakawa, K. The fecal flora in man. I. Composition of the fecal flora of various age groups [German]. Zentralbl. Bakteriol. Orig. A. 223, 333-342 (1973).
124. Hopkins, M. J., Sharp, R. &Macfarlane, G. T. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48, 198-205 (2001).
125. Gavini, F. et al. Differences in distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children, adults, elderly) age groups. Microb. Ecol. Health Dis. 13, 40-45 (2001).
126. Saunier, K. &Dor, J. Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig. Liver Dis. 34 (Suppl. 2), S19-S24 (2002).
127. Tamboli, C. P., Neut, C., Desreumaux, P. &Colombel, J. F. Dysbiosis in inflammatory bowel disease. Gut 53, 1-4 (2004).
128. Sartor, R. D. Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577-594 (2008).
129. Cucchiara, S., Iebba, V., Conte, M. P. &Schippa, S. The microbiota in inflammatory bowel disease in different age groups. Dig. Dis. 27, 252-258 (2009).
130. Glasser, A. L. et al. Adherent invasive Escherichia coli strains from patients with Crohns disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69, 5529-5537 (2001).
131. Conte, M. P. et al. Gut-Associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55, 1760-1767 (2006).
132. De Cruz, P. et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm. Bowel Dis. 18, 372-390 (2012).
133. Kim, S. C. et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128, 891-906 (2005).
134. Wakabayashi, A., Utsuyama, M., Hosoda, T., Sato, K. &Hirokawa, K. Differential age effect of oral administration of an antigen on antibody response: an induction of tolerance in young mice but enhancement of immune response in old mice. Mech. Ageing Dev. 109, 191-201 (1999).
135. Kato, H. et al. Lack of oral tolerance in aging is due to sequential loss of Peyers patch cell interactions. Int. Immunol. 15, 145-158 (2003).
136. de Faria, A. M. et al. Aging affects oral tolerance induction but not its maintenance in mice. Mech. Ageing Dev. 102, 67-80 (1998).
137. Fujihashi, K. &Kiyono, H. Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol. 30, 334-343 (2009).
138. Yung, R. L. &Julius, A. Epigenetics, aging, and autoimmunity. Autoimmunity 41, 329-335 (2008).
139. Pawelec, G. (1999). Immunosenescence: impact in the young as well as the old? Mech. Ageing Dev. 108, 1-7 (1999).
140. Linton, P. J. &Dorshkind, K. Age-related changes in lymphocyte development and function. Nat. Immunol. 5, 133-139 (2004).
141. Lynch, H. E. et al. Thymic involution and immune reconstitution. Trends Immunol. 30, 366-373 (2009).
142. Min, H., Montecino-Rodriguez, E. &Dorshkind, K. Effects of aging on the common lymphoid progenitor to pro-B cell transition. J. Immunol. 176, 1007-1012 (2006).
143. Alter-Wolf, S., Blomberg, B. B. &Riley, R. L. Deviation of the B cell pathway in senescent mice is associated with reduced surrogate light chain expression and altered immature B cell phenotype, and light chain expression. J. Immunol. 182, 138-147 (2009).
144. Sudo, K., Ema, H., Morita, Y. &Nakauchi, H. Age-Associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 192, 1273-1280 (2000).
145. Min, H., Montecino-Rodriguez, E. &Dorshkind, K. Effects of aging on early B- and T-cell development. Immunol. Rev. 205, 7-17 (2005).
146. Rossi, D. J. et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl Acad. Sci. USA 102, 9194-9199 (2005).
147. Pang, W. W. et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl Acad. Sci. USA 108, 20012-20017 (2011).
148. Challen, G. A., Boles, N. C., Chambers, S. M. &Goodell, M. A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-?1. Cell Stem Cell 6, 265-278 (2010).
149. Stephan, R. P., Reilly, C. R. &Witte, P. L. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 91, 75-88 (1998).
150. Labrie, J. E. 3rd, Sah, A. P., Allman, D. M., Cancro, M. P. &Gerstein, R. M. Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J. Exp. Med. 200, 411-423 (2004).
151. Naveiras, O. et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460, 259-263 (2009).
152. Chinn, I. K., Blackburn, C. C., Manley, N. R. &Sempowski, G. D. Changes in primary lymphoid organs with aging. Semin. Immunol. 24, 309-320 (2012).
153. Dixit, V. D. Impact of immune-metabolic interactions on age-related thymic demise and T cell senescence. Semin. Immunol. 24, 321-330 (2012).
154. Taub, D. D., Murphy, W. J. &Longo, D. L. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr. Opin. Pharmacol. 10, 408-424 (2010).
155. Dorshkind, K. &Horseman, N. D. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 21, 292-312 (2000).
156. Nikolich-ugich, J., Li, G., Uhrlaub, J. L., Renkema, K. R. &Smithey, M. J. Age-related changes in CD8 T cell homeostasis and immunity to infection. Semin. Immunol. 24, 356-364 (2012).
157. Li, G. et al. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat. Med. 18, 1518-1524 (2012).
158. Haynes, L. &Lefebvre, J. S. Age-related deficiencies in antigen-specific CD4 T cell responses: lessons from mouse models. Aging Dis. 2, 374-381 (2011).
159. Shi, Y. et al. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J. Immunol. 175, 3262-3267 (2005).
160. Frasca, D. &Blomberg, B. B. Effects of aging on B cell function. Curr. Opin. Immunol. 21, 425-430 (2009).
161. Montecino-Rodriguez, E., Berent-Maoz, B. &Dorshkind, K. Causes, consequences, and reversal of immune system aging. J. Clin. Invest. 123, 958-965 (2013).
162. Gibson, K. L. et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 8, 18-25 (2009).
163. Agrawal, A. et al. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 178, 6912-6922 (2007).
164. Della Bella, S. et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin. Immunol. 122, 220-228 (2007).
165. Jing, Y. et al. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum. Immunol. 70, 777-784 (2009).
166. Lung, T. L., Saurwein-Teissl, M., Parson, W., Schönitzer, D. &Grubeck-Loebenstein, B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18, 1606-1612 (2000).
167. Panda, A. et al. Age-Associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 184, 2518-2527 (2010).
168. Park, S., Kang, S., Min, K. H., Woo Hwang, K. &Min, H. Age-Associated changes in microRNA expression in bone marrow derived dendritic cells. Immunol. Invest. 42, 179-190 (2013).
169. Plowden, J., Renshaw-Hoelscher, M., Engleman, C., Katz, J. &Sambhara, S. Innate immunity in aging: impact on macrophage function. Aging Cell 3, 161-167 (2004).
170. F?l?p, T. Jr, F?ris, G., W?rum, I. &Le?vey, A. Age-dependent alterations of Fc ? receptor-mediated effector functions of human polymorphonuclear leucocytes. Clin. Exp. Immunol. 61, 425-432 (1985).
171. Butcher, S. K. et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J. Leukoc. Biol. 70, 881-886 (2001).
172. Kawanishi, H. &Kiely, J. Immune-related alterations in aged gut-Associated lymphoid tissues in mice. Dig. Dis. Sci. 34, 175-184 (1989).
173. Koga, T. et al. Evidence for early aging in the mucosal immune system. J. Immunol. 165, 5352-5359 (2000).
174. McDonald, K. G., Leach, M. R., Huang, C., Wang, C. &Newberry, R. D. Aging impacts isolated lymphoid follicle development and function. Immun. Ageing 8, 1 (2011).
175. Schmucker, D. L., Daniels, C. K., Wang, R. K. &Smith, K. Mucosal immune response to cholera toxin in ageing rats. I. Antibody and antibody-containing cell response. Immunology 64, 691-695 (1988).
176. Thoreux, K., Owen, R. L. &Schmucker, D. L. Intestinal lymphocyte number, migration and antibody secretion in young and old rats. Immunology 101, 161-167 (2000).
177. Van Kruiningen, H. J., West, A. B., Freda, B. J. &Holmes, K. A. Distribution of Peyers patches in the distal ileum. Inflamm. Bowel Dis. 8, 180-185 (2002).
178. Van Kruiningen, H. J., Ganley, L. M. &Freda, B. J. The role of Peyers patches in the age-related incidence of Crohns disease. J. Clin. Gastroenterol. 25, 470-475 (1997).
179. Dukes, C. &Bussey, H. J. R. The number of lymphoid follicles in the human large intestine. J. Pathol. Bact. 29, 111-116 (1926).
180. Targan, S. R. et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohns disease. Gastroenterology 128, 2020-2028 (2005).
181. Ferrante, M. et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56, 1394-1403 (2007).
182. Markowitz, J. et al. Age of diagnosis influences serologic responses in children with Crohns disease: a possible clue to etiology? Inflamm. Bowel Dis. 15, 714-719 (2009).